- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 4, 2023
Distillery Therapeutics
A trivalent nanoparticle vaccine for Merbecoviruses and Sarbecoviruses
BioCentury | Feb 5, 2020
Product Development
2019-nCoV drug discovery: HHS funds Regeneron mAbs and BenevolentAI deploys machine learning
BioCentury | May 2, 2019
Emerging Company Profile
SAB: Human polyclonal antibodies on the hoof
SAB uses cows, goats to overcome limitations of generating polyclonal antibodies
Items per page:
1 - 8 of 8